Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
doi:10.1016/s0016-5085(00)70251-4 Tougas G, Snape WJ, Jr., Otten MH, et al
No completed human clinical trials exist as of 2026
2025 Exhibit 103: PBM Selection Factors, by Type of Plan Sponsor, 2025 Exhibit 104: Adoption of PBM National Formulary, by Type of Plan Sponsor, 2025 Exhibit 105: Number of Products on PBM Formulary Exclusion Lists, by PBM, 2012 to 2026 Exhibit 106: Number of Unique Products on PBM Formulary Exclusion Lists, Single-Source vs
The connection lies in how these medications alter gastric motilitythe muscle contractions that move food through your digestive system
assessed the metabolic reprogramming in tumors and found that metabolic signals were cross-linked between PDAC and CAFs